San Diego Scientists Help Develop New Twist On In Vitro Fertilization
By David Wagner,
KPBS
| 11. 10. 2016
A team of researchers including scientists from San Diego have developed a new approach to in vitro fertilization that combines components from the eggs of two different women. They say if follow-up studies prove successful, it could one day improve treatments for infertility or help prevent devastating diseases.
But some experts are concerned that this and similar approaches, which have already reportedly been used in a number of human births, have not yet been proven safe.
The new technique involves extracting tiny cells called polar bodies from the egg of a woman who may be struggling with infertility or may be at risk of passing down mitochondrial disease to her children. Polar bodies normally play no role in fertilization, but they can when they're implanted into a healthier egg from a donor.
In a new study published Thursday in Cell Stem Cell, researchers co-led by the Salk Institute's Joseph Ecker show that when this hybrid egg is fertilized, it can give rise to cells that appear capable of becoming viable human embryos. These embryos could contain DNA from...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...